Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CU-20401 for submental fat reduction (Phase II)
CTR20233769Phase 2Completed
- Sponsor
- Codexis, Inc.
- Start
- Dec 2023
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in submental fat comparing CU-20401 with Placebo (2 arms). Primary endpoint: Proportion of subjects with at least 1-grade improvement in both CR-SMFRS and PR-SMFRS at Day 29. Started Dec 2023; status: completed.
02
Drugs
CU-20401
03
Conditions
submental fat
Beyond the preview
Go deeper on CTR20233769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233769.